Abstract
Objective: To examine the mortality rate and causes of death in a cohort of 300 patients with systemic lupus erythematosus (SLE).
Methods: A retrospective analysis was performed on all patients attending the SLE clinic between 1978 and 2000. Information was obtained on those patients lost to follow up. Cause of death was analysed and categorised as early (<5 years after diagnosis of SLE) and late (>5 years after diagnosis of SLE). Standardised mortality rates were obtained.
Results: The patients were followed up for a median of 8.3 years. Seventy three (24%) patients were no longer followed up at the end of the study period, of whom 41 (14%) had died. Of the 32 patients lost to follow up, 14 were being actively followed up within the UK, 16 were followed up outside the UK, and two patients were untraceable. The most common cause of death was malignancy, which accounted for eight (20%) deaths, followed by infection and vascular disease, which accounted for seven (17%) deaths each.
Conclusions: Malignancy was the most common cause of death. Cause of death varied depending on disease duration. Forty per cent of early deaths were due to SLE related renal disease, whereas 23% of late deaths were due to vascular causes. Death due to infection occurred throughout the follow up period. There was a fourfold increased risk of death in our cohort of patients with SLE compared with the general population.
Full Text
The Full Text of this article is available as a PDF (97.9 KB).
Figure 1 .
Number of deaths according to length of follow up.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abu-Shakra M., Urowitz M. B., Gladman D. D., Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol. 1995 Jul;22(7):1259–1264. [PubMed] [Google Scholar]
- Abu-Shakra M., Urowitz M. B., Gladman D. D., Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol. 1995 Jul;22(7):1265–1270. [PubMed] [Google Scholar]
- Badui E., Garcia-Rubi D., Robles E., Jimenez J., Juan L., Deleze M., Diaz A., Mintz G. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology. 1985 Jul;36(7):431–441. doi: 10.1177/000331978503600705. [DOI] [PubMed] [Google Scholar]
- Bhalla R., Ajmani H. S., Kim W. W., Swedler W. I., Lazarevic M. B., Skosey J. L. Systemic lupus erythematosus and Hodgkin's lymphoma. J Rheumatol. 1993 Aug;20(8):1316–1320. [PubMed] [Google Scholar]
- Bidani A. K., Roberts J. L., Schwartz M. M., Lewis E. J. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med. 1980 Dec;69(6):849–858. doi: 10.1016/s0002-9343(80)80010-6. [DOI] [PubMed] [Google Scholar]
- Drenkard C., Villa A. R., Alarcón-Segovia D., Pérez-Vázquez M. E. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol. 1994 Jun;21(6):1067–1072. [PubMed] [Google Scholar]
- Ginzler E. M., Diamond H. S., Weiner M., Schlesinger M., Fries J. F., Wasner C., Medsger T. A., Jr, Ziegler G., Klippel J. H., Hadler N. M. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum. 1982 Jun;25(6):601–611. doi: 10.1002/art.1780250601. [DOI] [PubMed] [Google Scholar]
- Helve T. Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand J Rheumatol. 1985;14(1):43–46. doi: 10.3109/03009748509102015. [DOI] [PubMed] [Google Scholar]
- Jacobsen S., Petersen J., Ullman S., Junker P., Voss A., Rasmussen J. M., Tarp U., Poulsen L. H., van Overeem Hansen G., Skaarup B. Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol. 1999;28(2):75–80. doi: 10.1080/030097499442522. [DOI] [PubMed] [Google Scholar]
- Jonsson H., Nived O., Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore) 1989 May;68(3):141–150. [PubMed] [Google Scholar]
- Lee P., Urowitz M. B., Bookman A. A., Koehler B. E., Smythe H. A., Gordon D. A., Ogryzlo M. A. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med. 1977 Jan;46(181):1–32. [PubMed] [Google Scholar]
- MERRELL M., SHULMAN L. E. Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis. 1955 Jan;1(1):12–32. doi: 10.1016/0021-9681(55)90018-7. [DOI] [PubMed] [Google Scholar]
- Mellemkjaer L., Andersen V., Linet M. S., Gridley G., Hoover R., Olsen J. H. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum. 1997 Apr;40(4):761–768. doi: 10.1002/art.1780400424. [DOI] [PubMed] [Google Scholar]
- Menon S., Snaith M. L., Isenberg D. A. The association of malignancy with SLE: an analysis of 150 patients under long-term review. Lupus. 1993 Jun;2(3):177–181. doi: 10.1177/096120339300200309. [DOI] [PubMed] [Google Scholar]
- Pistiner M., Wallace D. J., Nessim S., Metzger A. L., Klinenberg J. R. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum. 1991 Aug;21(1):55–64. doi: 10.1016/0049-0172(91)90057-7. [DOI] [PubMed] [Google Scholar]
- Reveille J. D., Bartolucci A., Alarcón G. S. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 1990 Jan;33(1):37–48. doi: 10.1002/art.1780330105. [DOI] [PubMed] [Google Scholar]
- Rosner S., Ginzler E. M., Diamond H. S., Weiner M., Schlesinger M., Fries J. F., Wasner C., Medsger T. A., Jr, Ziegler G., Klippel J. H. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum. 1982 Jun;25(6):612–617. doi: 10.1002/art.1780250602. [DOI] [PubMed] [Google Scholar]
- Rubin L. A., Urowitz M. B., Gladman D. D. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med. 1985 Apr;55(216):87–98. [PubMed] [Google Scholar]
- Studenski S., Allen N. B., Caldwell D. S., Rice J. R., Polisson R. P. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum. 1987 Dec;30(12):1326–1332. doi: 10.1002/art.1780301202. [DOI] [PubMed] [Google Scholar]
- Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
- Tucker L. B., Menon S., Schaller J. G., Isenberg D. A. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol. 1995 Sep;34(9):866–872. doi: 10.1093/rheumatology/34.9.866. [DOI] [PubMed] [Google Scholar]
- Uramoto K. M., Michet C. J., Jr, Thumboo J., Sunku J., O'Fallon W. M., Gabriel S. E. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 1999 Jan;42(1):46–50. doi: 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
- Urowitz M. B., Bookman A. A., Koehler B. E., Gordon D. A., Smythe H. A., Ogryzlo M. A. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976 Feb;60(2):221–225. doi: 10.1016/0002-9343(76)90431-9. [DOI] [PubMed] [Google Scholar]
- Urowitz M. B., Gladman D. D., Abu-Shakra M., Farewell V. T. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol. 1997 Jun;24(6):1061–1065. [PubMed] [Google Scholar]
- Wallace D. J., Podell T., Weiner J., Klinenberg J. R., Forouzesh S., Dubois E. L. Systemic lupus erythematosus--survival patterns. Experience with 609 patients. JAMA. 1981 Mar 6;245(9):934–938. doi: 10.1001/jama.245.9.934. [DOI] [PubMed] [Google Scholar]
- Ward M. M., Pyun E., Studenski S. Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum. 1995 Oct;38(10):1492–1499. doi: 10.1002/art.1780381016. [DOI] [PubMed] [Google Scholar]
- Ward M. M., Pyun E., Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum. 1995 Feb;38(2):274–283. doi: 10.1002/art.1780380218. [DOI] [PubMed] [Google Scholar]
- Wilson H. A., Hamilton M. E., Spyker D. A., Brunner C. M., o'Brien W. M., Davis J. S., 4th, Winfield J. B. Age influences the clinical and serologic expression of systemic lupus erythematosus. Arthritis Rheum. 1981 Oct;24(10):1230–1235. doi: 10.1002/art.1780241002. [DOI] [PubMed] [Google Scholar]
- Worrall J. G., Snaith M. L., Batchelor J. R., Isenberg D. A. SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up. Q J Med. 1990 Mar;74(275):319–330. [PubMed] [Google Scholar]